Fubo Chen
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Shengcai Qi (11 shared papers)Kun Zhang (4 shared papers)Taixia Wang (3 shared papers)Raorao Wang (4 shared papers)Yuanzhi Xu (7 shared papers)Jianjun Yang (1 shared paper)Rong Zhou (3 shared papers)Qing Zhao (1 shared paper)
In The Last Decade
Fubo Chen
23 papers receiving 341 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 48
- Periodontics 10
- Emergency Medical Services 13
- Biomedical Engineering 89
- Biomaterials 25
Countries citing papers authored by Fubo Chen
This map shows the geographic impact of Fubo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fubo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fubo Chen more than expected).
Fields of papers citing papers by Fubo Chen
This network shows the impact of papers produced by Fubo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fubo Chen. The network helps show where Fubo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fubo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 51 | |
| 2 | 2023 | 50 | |
| 3 | 2018 | 39 | |
| 4 | 2023 | 27 | |
| 5 | 2024 | 25 | |
| 6 | 2022 | 25 | |
| 7 | 2019 | 19 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 15 | |
| 10 | 2014 | 15 | |
| 11 | 1989 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2017 | 8 | |
| 14 | 2018 | 8 | |
| 15 | The Effect of NRAGE on cell cycle and apoptosis of human dental pulp cells and MDPC-23. | 2015 | 7 |
| 16 | 2020 | 5 | |
| 17 | Porphyromonas gingivalis induced UCHL3 to promote colon cancer progression. | 2023 | 4 |
| 18 | 2020 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Fubo Chen
Fubo Chen is a scholar working on Molecular Biology, Biomedical Engineering, Epidemiology, Rheumatology and Materials Chemistry, having authored 23 papers that have together received 347 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (3 papers), Nanoplatforms for cancer theranostics (3 papers), Bone and Dental Protein Studies (2 papers), Underwater Vehicles and Communication Systems (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Cancer Research and Treatments (2 papers), Chemical Reactions and Mechanisms (1 paper) and Plant-based Medicinal Research (1 paper). The work is most often cited by research in Cancer Research (48 citations), Periodontics (10 citations), Emergency Medical Services (13 citations), Biomedical Engineering (89 citations) and Biomaterials (25 citations). Fubo Chen has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Shengcai Qi, Kun Zhang, Taixia Wang, Raorao Wang, Yuanzhi Xu, Jianjun Yang, Rong Zhou, Qing Zhao, Xu Zhang and Jinjin Wu. Their work appears in journals such as Clinical Oral Investigations, Cell Proliferation, Frontiers in Bioengineering and Biotechnology, Oral Diseases and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.